Trials / Completed
CompletedNCT01464840
The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly involved in post-cesarean infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin | 500 mg intravenous infused over 1 hour |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-05-01
- Completion
- 2013-08-01
- First posted
- 2011-11-04
- Last updated
- 2017-05-11
- Results posted
- 2014-01-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01464840. Inclusion in this directory is not an endorsement.